T5O0 — bioXXmed AG Share News
0.000.00%
Last trade - 00:00- €1.07m
- €0.98m
- €0.02m
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)
Brief: CytoTools Says Annual General Meeting Canceled
Brief: CytoTools Cures Resolution Of 2020 Annual General Meeting With Proposed Capital Increase
Brief: CytoTools To Propose Ordinary Capital Increase
Brief: CytoTools Reports Treatment Numbers In India Slightly Above Previous Quarter
Brief: CytoTools Signs Collaboration Agreement To Develop Inhalation Therapy For Viral Infections Such As COVID-19, Influenza
Brief: CytoTools Sees Roll-Out Of Woxheal In India To Be Completed In 2021
Brief: CytoTools Receives Confirmation Of Efficacy Of DPCOL Also Against Influenza Viruses
Brief: CytoTools: Shareholder Group Blocks Parts Of AGM Agenda With Capital Majority
Brief: CytoTools Announces Confirmed Efficacy Of DPOCL In COVID-19
Brief: CytoTools To Propose Creation Of New Authorized Capital
Brief: CytoTools Says Marc Herwick Appointed Chief Financial Officer
Brief: CytoTools Examines Effectiveness Of Patented Active Substance DPOCL In Covid-19 Infections
Brief: CytoTools Partner Centaur Pharmaceuticals Starts Marketing Active Substance DPOCL In India
Brief: CytoTools Introduces New Strategic Investor
Brief: CytoTools Postpones AGM To End Of October